The global market for vaccine delivery devices should grow from $3.7 billion in 2021 to $4.4 billion by 2026, at a compound annual growth rate (CAGR) of 3.8% for the period of 2021-2026.
Report Scope
This report provides a detailed description of vaccine delivery devices and the latest technologies in the market. The report includes market estimates for different types of vaccine delivery devices. The report also includes recent technological developments and assessments of product performance in the market.
Based on the device type, the vaccine delivery device market is segmented into syringes, jet injectors and other novel technologies (e.g., microneedle patches, electroporation-based needle-free injection system, nasal spray, etc.).
Based on the route of administration, the vaccine delivery device market is segmented into intramuscular injection, subcutaneous injection and other routes of administration (intradermal, oral route, etc.).
Based on end-users, the vaccine delivery device market is segmented into hospitals, clinics and other end-users (vaccination centers, tertiary care centers, etc.).
The report includes a list of pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing the market growth, as well as market drivers, restraints and opportunities.
This report also discusses competition in the global vaccine delivery device market and the key players’ strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes the company profiles of major vendors including company overview, key product offerings, financial statistics and recent developments. The report provides insights on the market share and upcoming regional demand for vaccine delivery devices.
Some of the major market players discussed in the report are BD, ApiJect Systems Corp., Hindustan Syringes & Medical Devices Ltd., Terumo Corp. and Smiths Medical. For market estimates, data has been provided for the year 2019 as the base year, with forecasts for 2021 through 2026. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
The Report Includes
- 55 tables
- An overview of the global markets for vaccine delivery systems
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast and technological advancements and strategic innovations within the industry
- Highlights of the market potential for vaccine delivery systems by type of device, route of administration, end user, and region
- Discussion on vaccines limitations like inefficient activation of a cell-mediated immune response and the deficiency of protective mucosal immunity, and information on gene-based vaccines like DNA & m-RNA vaccines
- Coverage of recent developments which have been focused on intradermal vaccine formulations for vaccine delivery devices to activate both a systemic and mucosal immune response
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Profile descriptions of the leading industry players including ApiJect Systems Corp., Corium Inc., Enesi Pharma, Hindustan Syringes & Medical Devices Ltd., PharmaJet, and SCHOTT.
Table of Contents
Chapter 1 Introduction
- Study Background
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
- Vaccines and Immunization: Overview
- Types of Vaccines
- Attenuated (Live) Vaccines
- Inactivated (Killed) Vaccines
- Toxoid Vaccines
- Subunit Vaccines
- Conjugate Vaccines
- Recombinant Vector Vaccines
- DNA Vaccines
- RNA Vaccines
- Immunization
- Types of Vaccine Delivery Devices
- Syringes
- Jet Injectors
- Microarray Patches (Microneedle Patches)
- Electroporation-Based Needle-Free Injections
- Nasal Spray
- Route of Administration
- Injectable Route
- Intramuscular Injections
- Subcutaneous Injections
- Intradermal Injections
- Oral Route
- Intranasal Route
- Regulatory Aspects: Vaccine Recommendations and Guidelines of the ACIP
- Safe Use of Needles and Syringes
- Regulatory Pathways for Jet Injectors
- Regulatory Pathways for Microarray Patches
Chapter 4 Impact of COVID-19 Pandemic
- Impact of COVID-19 on Vaccine Supplies
- Formation of COVAX
- COVAX Facility
- Need for COVAX
- Impact of COVID-19 on Routine Immunization
- Impact of COVID-19 on Syringe Supplies
- Shortage of Low Dead-Space Specialty Syringes
- South Korean Company to Double Syringe Supplies for a COVID-19 Vaccine Campaign
- Optimistic Impact of COVD-19 on Syringe Manufacturers
Chapter 5 Vaccine Delivery Device Market Dynamics
- Market Drivers
- Growing Awareness of Immunization Across the Globe
- Growing Investments and Support in R&D for New Vaccines
- Rising Technological and Manufacturing Advancements in Vaccine Delivery Devices
- Growing Incidence of Pandemic Outbreaks
- Growing Cases of Needle Phobia
- Market Restraints
- Comparative High Cost of Needle-Free Technology, especially in Emerging Countries
- Stringent Government Regulations
- Market Opportunities
- Opportunities in Emerging Nations
- Competitive Landscape
Chapter 6 Market Breakdown by Device
- Global Vaccine Delivery Device Market by Device Type
- Syringes
- Market Size and Forecast
- Jet Injectors
- Market Size and Forecast
- Others
- Market Size and Forecast
Chapter 7 Market Breakdown by Route of Administration
- Global Vaccine Delivery Devices Market by Route of Administration
- Intramuscular Injection
- Market Size and Forecast
- Subcutaneous Injection
- Market Size and Forecast
- Others
- Market Size and Forecast
Chapter 8 Market Breakdown by End User
- Global Vaccine Delivery Devices Market by End User
- Hospitals
- Market Size and Forecast
- Clinics
- Market Size and Forecast
- Others
- Market Size and Forecast
Chapter 9 Market Breakdown by Region
- Global Market for Vaccine Delivery Devices by Region
- North America
- United States
- Canada
- Europe
- Russia
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Indonesia
- Rest of Asia-Pacific
- Rest of World
- Market Size and Forecast
Chapter 10 Market Breakdown by Type of Vaccine Technology
- Global Vaccine Delivery Device Market by Type of Vaccine Technology
- Conjugate Vaccines
- Inactivated Vaccines
- Attenuated (Live) Vaccines
- DNA/rDNA Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Other/Combination Vaccines
Chapter 11 Industry Events
- Market Strategies
- Key Mergers and Acquisitions
- Companies
- Key Product and Technology Developments
- Companies
Chapter 12 Key Pipeline Products
- Key Pipeline Products
- MicroCor
- The ImplaVax Technology
- TriGrid Delivery System
- Kindeva Drug Delivery
- VAXXAS Pty Ltd.
Chapter 13 Company Profiles
- Apiject Systems Corp.
- BD
- Corium Inc.
- D'antonio Consultants International Inc.
- Enesi Pharma
- Hindustan Syringes & Medical Devices Ltd.
- Ichor Medical Systems Inc.
- Kindeva Drug Delivery (Formerly 3M)
- Medical International Technologies (Mit Canada) Inc.
- Nanopass Technologies Ltd.
- Pharmajet
- Schott Ag
- Smiths Medical
- Terumo Corp.
- Theraject Inc.
- Vaxxas Pty Ltd.
- West Pharmaceutical Services Inc.
Chapter 14 Appendix: Acronyms
List of Tables
Summary Table: Global Market for Vaccine Delivery Devices, by Type, Through 2026
Table 1: Advantages and Disadvantages of Attenuated (Live) Vaccines
Table 2: Advantages and Disadvantages of Inactivated (Killed) Vaccines
Table 3: Advantages and Disadvantages of Toxoid Vaccines
Table 4: Advantages and Disadvantages of Subunit Vaccines
Table 5: Advantages and Disadvantages of Conjugate Vaccines
Table 6: Advantages and Disadvantages of Recombinant Vector Vaccines
Table 7: Advantages and Disadvantages of DNA Vaccines
Table 8: Advantages and Disadvantages of RNA Vaccines
Table 9: Microarray Patch Development Status
Table 10: Status of Development of Certain Intradermal Vaccines
Table 11: Dose and Route of Administration for Selected Vaccines
Table 12: Global Vaccine Delivery Device Market, by Vendor Ranking, 2020
Table 13: Global Market for Vaccine Delivery Devices, by Device Type, Through 2026
Table 14: Global Market for Vaccine Delivery Syringes, by Region, Through 2026
Table 15: Global Market for Jet Injectors in Vaccine Delivery Devices, by Region, Through 2026
Table 16: Global Market for Other Vaccine Delivery Devices, by Region, Through 2026
Table 17: Global Market for Vaccine Delivery Devices, by Route of Administration, Through 2026
Table 18: Global Market for Intramuscular Injection in Vaccine Delivery Devices, by Region, Through 2026
Table 19: Global Market for Subcutaneous Injection in Vaccine Delivery Devices, by Region, Through 2026
Table 20: Global Market for Other Routes of Administration of Vaccine Delivery Devices, by Region, Through 2026
Table 21: Global Market for Vaccine Delivery Devices, by End User, Through 2026
Table 22: Global Market for Vaccine Delivery Devices in Hospitals, by Region, Through 2026
Table 23: Global Market for Vaccine Delivery Devices in Healthcare Clinics, by Region, Through 2026
Table 24: Global Market for Other End Users of Vaccine Delivery Devices, by Region, Through 2026
Table 25: Global Market for Vaccine Delivery Devices, by Region, Through 2026
Table 26: North American Market for Vaccine Delivery Devices, by Device Type, Through 2026
Table 27: North American Market for Vaccine Delivery Devices, by Country, Through 2026
Table 28: European Market for Vaccine Delivery Devices, by Device Type, Through 2026
Table 29: European Market for Vaccine Delivery Devices, by Country, Through 2026
Table 30: Asia-Pacific Market for Vaccine Delivery Devices, by Device Type, Through 2026
Table 31: Asia-Pacific Market for Vaccine Delivery Devices, by Country, Through 2026
Table 32: Rest of the World Market for Vaccine Delivery Devices, by Device Type, Through 2026
Table 33: Rest of the World Market for Vaccine Delivery Devices, by Sub-Region, Through 2026
Table 34: Key Pipeline Products in Global Vaccine Delivery Device Market
Table 35: ApiJect Systems Corp.: Products/Services
Table 36: ApiJect Systems Corp.: Recent Developments
Table 37: BD: Products/Services Offered
Table 38: BD: Recent Developments
Table 39: Enesi Pharma: Recent Developments
Table 40: Hindustan Syringes and Medical Devices Ltd.: Products/Services
Table 41: Ichor Medical Systems Inc.: Recent Developments
Table 42: Medical International Technologies (MIT Canada) Inc.: Products/Services
Table 43: NanoPass Technologies Ltd.: Products/Services
Table 44: NanoPass Technologies Ltd.: Recent Developments
Table 45: PharmaJet: Products/Services
Table 46: PharmaJet: Recent Developments
Table 47: SCHOTT AG: Products/Services
Table 48: SCHOTT AG: Recent Developments
Table 49: Smiths Medical: Products/Services
Table 50: Smiths Medical: Recent Developments
Table 51: Terumo Corp.: Products/Services Offered
Table 52: Terumo Corp.: Recent Developments
Table 53: Vaxxas Pty Ltd.: Recent Developments
Table 54: West Pharmaceutical Services Inc.: Products/Services
Table 55: Acronyms Used in the Global Vaccine Delivery Device Market
List of Figures
Summary Figure: Global Market Shares of Vaccine Delivery Devices, by Type, 2020
Figure 1: Microarray Patches: Drug Delivery Methods
Figure 2: Global Market Shares of Vaccine Delivery Devices, by Device Type, 2020
Figure 3: Global Market for Vaccine Delivery Syringes, 2019-2026
Figure 4: Global Market for Vaccine Delivery Syringes, by Region, 2019-2026
Figure 5: Global Market for Vaccine Delivery Jet Injector Devices, 2019-2026
Figure 6: Global Market for Jet Injectors in Vaccine Delivery Devices, by Region, 2019-2026
Figure 7: Global Market for Other Vaccine Delivery Devices, 2019-2026
Figure 8: Global Market for Other Vaccine Delivery Devices, by Region, 2019-2026
Figure 9: Global Market Shares of Vaccine Delivery Devices, by Route of Administration, 2020
Figure 10: Global Market for Intramuscular Injection in Vaccine Delivery Devices, 2019-2026
Figure 11: Global Market for Intramuscular Injection in Vaccine Delivery Devices, by Region, 2019-2026
Figure 12: Global Market for Subcutaneous Injection in Vaccine Delivery Devices, 2019-2026
Figure 13: Global Market for Subcutaneous Injection in Vaccine Delivery Devices, by Region, 2019-2026
Figure 14: Global Market for Other Routes of Administration of Vaccine Delivery Devices, 2019-2026
Figure 15: Global Market for Other Routes of Administration of Vaccine Delivery Devices, by Region, 2019-2026
Figure 16: Global Market Shares of Vaccine Delivery Devices, by End User, 2020
Figure 17: Global Market for Vaccine Delivery Devices in Hospitals, 2019-2026
Figure 18: Global Market for Vaccine Delivery Devices in Hospitals, by Region, 2019-2026
Figure 19: Global Market for Vaccine Delivery Devices in Healthcare Clinics, 2019-2026
Figure 20: Global Market for Vaccine Delivery Devices in Healthcare Clinics, by Region, 2019-2026
Figure 21: Global Market for Other End Users of Vaccine Delivery Devices, 2019-2026
Figure 22: Global Market for Other End Users of Vaccine Delivery Devices, by Region, 2019-2026
Figure 23: Global Market for Vaccine Delivery Devices, by Region, 2019-2026
Figure 24: Global Market Shares of Vaccine Delivery Devices, by Region, 2020
Figure 25: North American Market Shares of Vaccine Delivery Devices, by Device Type, 2020
Figure 26: North American Market Share for Vaccine Delivery Devices, by Country, 2020
Figure 27: U.S. Market for Vaccine Delivery Devices, 2019-2026
Figure 28: Canadian Market for Vaccine Delivery Devices, 2019-2026
Figure 29: European Market Shares of Vaccine Delivery Devices, by Device Type, 2020
Figure 30: European Market Shares of Vaccine Delivery Devices, by Country, 2020
Figure 31: Russian Market for Vaccine Delivery Devices, 2019-2026
Figure 32: German Market for Vaccine Delivery Devices, 2019-2026
Figure 33: U.K. Market for Vaccine Delivery Devices, 2019-2026
Figure 34: French Market for Vaccine Delivery Devices, 2019-2026
Figure 35: Italian Market for Vaccine Delivery Devices, 2019-2026
Figure 36: Spanish Market for Vaccine Delivery Devices, 2019-2026
Figure 37: Rest of the European Market for Vaccine Delivery Devices, 2019-2026
Figure 38: Asia-Pacific Market Shares of Vaccine Delivery Devices, by Device Type, 2020
Figure 39: Asia-Pacific Market Shares of Vaccine Delivery Devices, by Country, 2020
Figure 40: Indian Market for Vaccine Delivery Devices, 2019-2026
Figure 41: Chinese Market for Vaccine Delivery Devices, 2019-2026
Figure 42: Japanese Market for Vaccine Delivery Devices, 2019-2026
Figure 43: Indonesian Market for Vaccine Delivery Devices, 2019-2026
Figure 44: Rest of Asia-Pacific Vaccine Delivery Devices Market, 2019-2026
Figure 45: Rest of the World Market Shares of Vaccine Delivery Devices, by Device Type, 2020
Figure 46: Rest of the World Market Shares of Vaccine Delivery Devices, by Sub-Region, 2020
Figure 47: Global Market Shares of Vaccine Delivery Devices, by Type of Vaccine Technology, 2020
Figure 48: BD: Net Revenue, 2016-2020
Figure 49: BD: Revenue Share, by Business Segment, 2020
Figure 50: BD: Revenue Share, by Region, 2020
Figure 51: SCHOTT AG: Net Revenue, 2016-2020
Figure 52: SCHOTT AG: Revenue Share, by Region, 2020
Figure 53: Smiths Medical: Net Revenue, 2016-2020
Figure 54: Smiths Medical: Revenue Share, by Business Segment, 2020
Figure 55: Smiths Medical: Revenue Share, by Region, 2020
Figure 56: Terumo Corp.: Net Revenues, 2016-2020
Figure 57: Terumo Corp.: Revenue Share, by Business Segment, 2020
Figure 58: Terumo Corp.: Revenue Share, by Region, 2020
Figure 59: West Pharmaceutical Services Inc.: Net Revenues, 2016-2020
Figure 60: West Pharmaceutical Services Inc.: Revenue Share, by Business Segment, 2020
Figure 61: West Pharmaceutical Services Inc.: Revenue Share, by Region, 2020
Samples
LOADING...
Executive Summary
The growing awareness of immunization by WHO and many governments and NGOs across the globe is one of the key factors driving the vaccine delivery device market. Some of the key factors influencing the growth of the market include the rising global pediatric population, especially in African countries; increasing immunization programs and their increasing coverage; new research in the field of vaccination; and extended support and investment by the government for R& D in vaccination.
The global vaccine delivery device market is segmented in this report by device type, route of administration, end-user and region.
Companies Mentioned
- Apiject Systems Corp.
- BD
- Corium Inc.
- D'antonio Consultants International Inc.
- Enesi Pharma
- Hindustan Syringes & Medical Devices Ltd.
- Ichor Medical Systems Inc.
- Kindeva Drug Delivery (Formerly 3M)
- Medical International Technologies (Mit Canada) Inc.
- Nanopass Technologies Ltd.
- Pharmajet
- Schott Ag
- Smiths Medical
- Terumo Corp.
- Theraject Inc.
- Vaxxas Pty Ltd.
- West Pharmaceutical Services Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | June 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 3.7 Billion |
| Forecasted Market Value ( USD | $ 4.4 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
